American tegumentary leishmaniasis - a case of therapeutic challenge

AUTOR(ES)

Couto, Daíne Vargas, Hans Filho, Gunter, Medeiros, Marcelo Zanolli, Vicari, Carolina Faria Santos, Barbosa, Aline Blanco, Takita, Luiz Carlos

FONTE

An. Bras. Dermatol.

DATA DE PUBLICAÇÃO

2014-12

RESUMO

American Tegumentary Leishmaniasis (ATL) is a chronic, non-contagious, infectious disease affecting millions of people worldwide. The timely and proper treatment is of great importance to prevent the disease from progressing to destructive and severe forms. Treatment for ATL recommended by the Brazilian Ministry of Health is similar for the whole country, regardless of the species of Leishmania. It is known that the response to treatment may vary with the strain of the parasite, the immune status of the patient and clinical form. We report the case of a healthy patient, coming from Manaus, Amazonas state, Brazil, who presented resistance to treatment with N-methyl-glutamine and liposomal amphotericin B, only being healed after using pentamidine.

Documentos Relacionados

• American tegumentary leishmaniasis: diagnostic and treatment challenges in a clinical case
• Periungual tegumentary leishmaniasis: a diagnostic challenge
• Clinico-immunological spectrum of American tegumentary leishmaniasis and leprosy coinfection: A case series in Southeastern Brazil
• Complementary exams in the diagnosis of american tegumentary leishmaniasis
• Treatment of American tegumentary leishmaniasis in special populations: a summary of evidence